Cargando…
GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized clinically by severe cognitive deficits and pathologically by amyloid plaques, neuronal loss, and neurofibrillary tangles. Abnormal amyloid β-protein (Aβ) deposition in the brain is often thought of as a major initiating factor i...
Autores principales: | Xu, Yilan, Zhao, Manna, Han, Yuying, Zhang, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344222/ https://www.ncbi.nlm.nih.gov/pubmed/32714136 http://dx.doi.org/10.3389/fnins.2020.00660 |
Ejemplares similares
-
A Comparative Perspective on Minicolumns and Inhibitory GABAergic Interneurons in the Neocortex
por: Raghanti, Mary Ann, et al.
Publicado: (2010) -
Implications of GABAergic Neurotransmission in Alzheimer’s Disease
por: Li, Yanfang, et al.
Publicado: (2016) -
Heterogeneity and Diversity of Striatal GABAergic Interneurons
por: Tepper, James M., et al.
Publicado: (2010) -
Id2 GABAergic interneurons comprise a neglected fourth major group of cortical inhibitory cells
por: Machold, Robert, et al.
Publicado: (2023) -
Heterogeneity and Diversity of Striatal GABAergic Interneurons: Update 2018
por: Tepper, James M., et al.
Publicado: (2018)